
Syria Conflict: Funding Concerns for Chemical Weapons Watchdog
The ongoing conflict in Syria raises concerns about US funding for the chemical weapons watchdog and the potential for further fragmentation of the country.
Quorum · collective opinions
Syria's Chemical Weapons File Closure and International Cooperation
First report 7h agoLast update 1h agoSyria is actively cooperating with the OPCW, providing over 100,000 documents and facilitating access to sites and records to address the Assad-era chemical weapons program.
The OPCW Director-General visited Syria and acknowledged tangible progress in addressing the chemical weapons program, highlighting practical cooperation and verified destruction of munitions.
The UK, at the UN Security Council, welcomed Syria's progress in addressing the deposed regime's chemical weapons legacy and emphasized the importance of respecting Syria's sovereignty.
Geopolitical Commentary and Syrian Fragmentation
First report 3h agoLast update 1h agoThere is a view that significant effort has been put into fragmenting Syria and the wider Middle East, a process that could happen to any state.
The world is more complex than media portrays, with revelations about ancient wells, Latin America, and the reasons behind Syria's perceived 'enemy' status.
Putin is viewed as an imperialist comparable to Western powers, capable of similar atrocities.
Syria's Chemical Weapons File and OPCW Engagement
First report 6h agoLast update 1h agoSyria is actively cooperating with the OPCW, providing documents and engaging in discussions to close the chemical weapons file.
The OPCW's work in Syria and elsewhere is crucial and should not be underfunded.
Syria Conflict and International Funding Concerns
First report 2h agoLast update 1h agoThe US has paid a portion of its dues to the OPCW, but funding shortages could impact Syria deployments to identify chemical weapons.
There are concerns about the fragmentation of Syria and the wider Middle East, suggesting it's not unique to Arab states.
iWitness comments
No comments yet — be the first to weigh in.